{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T17:17:09Z","timestamp":1776878229029,"version":"3.51.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260289"],"award-info":[{"award-number":["82260289"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC2000400"],"award-info":[{"award-number":["2018YFC2000400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Miaozi Project in Science and Technology Innovation Program of Sichuan Province","award":["2020JDRC0057"],"award-info":[{"award-number":["2020JDRC0057"]}]},{"name":"Basic Conditions Platform Construction Project of Sichuan Science and Technology Department","award":["2019JDPT0015"],"award-info":[{"award-number":["2019JDPT0015"]}]},{"name":"1.3.5 Project for disciplines of excellence, West China Hospital, Sichuan University","award":["ZYJC18003"],"award-info":[{"award-number":["ZYJC18003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to investigate the relationship between venous blood parameters and respiratory functions in patients with amyotrophic lateral sclerosis (ALS) and develop a model to predict respiratory impairment for individual patients with ALS. A total of 416 ALS patients were included in the study, and various hematologic and biochemical laboratory parameters as well as demographic and clinical factors were collected and compared. A multivariable logistic regression model was constructed to assess the association between FVC and venous blood biomarkers and clinical factors. The results showed that along with onset age, bulbar-onset, disease duration, BMI, eosinophil count (EO#), basophil count (BASO#), creatinine (CREA), uric acid (URCI) and low-density lipoprotein cholesterol\/high-density lipoprotein cholesterol (LDL\/HDL) ratio were associated with reduced FVC. The area under the ROC curve is 0.735 for the test set and 0.721 for the validation set. The study also developed a relatively acceptable model for predicting respiratory impairment in ALS patients. These findings suggest that EO#, BASO#, CREA, URIC and LDL\/HDL ratio can be useful in assessing FVC in ALS and can be easily accessible, accurate, and low-cost parameters.<\/jats:p>","DOI":"10.1038\/s41598-023-42075-4","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T09:03:32Z","timestamp":1695287012000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Venous blood parameters in determination of respiratory impairment in amyotrophic lateral sclerosis"],"prefix":"10.1038","volume":"13","author":[{"given":"Xianghua","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaming","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanzhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiyou","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"issue":"5","key":"42075_CR1","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","volume":"32","author":"E Longinetti","year":"2019","unstructured":"Longinetti, E. & Fang, F. Epidemiology of amyotrophic lateral sclerosis: An update of recent literature. Curr. Opin. Neurol. 32(5), 771\u2013776 (2019).","journal-title":"Curr. Opin. Neurol."},{"issue":"11","key":"42075_CR2","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1136\/jnnp-2017-315573","volume":"88","author":"A Eisen","year":"2017","unstructured":"Eisen, A. et al. Cortical influences drive amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 88(11), 917\u2013924 (2017).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"42075_CR3","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman, O. et al. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 3, 17071 (2017).","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"5","key":"42075_CR4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.neurol.2017.03.031","volume":"173","author":"M Soriani","year":"2017","unstructured":"Soriani, M. & Desnuelle, C. Care management in amyotrophic lateral sclerosis. Revue neurologique 173(5), 288\u2013299 (2017).","journal-title":"Revue neurologique"},{"issue":"3","key":"42075_CR5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1468-1331.2011.03501.x","volume":"19","author":"P Andersen","year":"2012","unstructured":"Andersen, P. et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur. J. Neurol. 19(3), 360\u2013375 (2012).","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"42075_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nbt.3051","volume":"33","author":"R K\u00fcffner","year":"2015","unstructured":"K\u00fcffner, R. et al. Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression. Nat. Biotechnol. 33(1), 51\u201357 (2015).","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"42075_CR7","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1001\/jamaneurol.2014.1129","volume":"71","author":"A Chi\u00f2","year":"2014","unstructured":"Chi\u00f2, A. et al. Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: A population-based study. JAMA Neurol. 71(9), 1134\u20131142 (2014).","journal-title":"JAMA Neurol."},{"issue":"12","key":"42075_CR8","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2169\/internalmedicine.51.7465","volume":"51","author":"K Ikeda","year":"2012","unstructured":"Ikeda, K., Hirayama, T., Takazawa, T., Kawabe, K. & Iwasaki, Y. Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: A cross-sectional study. Intern. Med. (Tokyo, Japan) 51(12), 1501\u20131508 (2012).","journal-title":"Intern. Med. (Tokyo, Japan)"},{"key":"42075_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/21678421.2020.1746810","volume":"21","author":"H Mitsumoto","year":"2020","unstructured":"Mitsumoto, H. et al. Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis. Amyotroph. Later. Scler. Frontotemporal Degener. 21, 263\u2013272 (2020).","journal-title":"Amyotroph. Later. Scler. Frontotemporal Degener."},{"issue":"5","key":"42075_CR10","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s10072-019-04201-x","volume":"41","author":"B Che\u0142stowska","year":"2020","unstructured":"Che\u0142stowska, B. & Ku\u017ama-Kozakiewicz, M. Biochemical parameters in determination of nutritional status in amyotrophic lateral sclerosis. Neurol. Sci. 41(5), 1115\u20131124 (2020).","journal-title":"Neurol. Sci."},{"key":"42075_CR11","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3233\/JND-200583","volume":"8","author":"J Morgadinho","year":"2021","unstructured":"Morgadinho, J. et al. Plasma creatinine level does not predict respiratory function in amyotrophic lateral sclerosis. J. Neuromuscul. Dis. 8, 795\u2013799 (2021).","journal-title":"J. Neuromuscul. Dis."},{"issue":"5","key":"42075_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks, B. R., Miller, R. G., Swash, M. & Munsat, T. L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Later. Scler. Other Mot. Neuron Disord. 1(5), 293\u2013299 (2000).","journal-title":"Amyotroph. Later. Scler. Other Mot. Neuron Disord."},{"key":"42075_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/21678421.2014.964258","volume":"16","author":"F Agosta","year":"2015","unstructured":"Agosta, F. et al. The El Escorial criteria: Strengths and weaknesses. Amyotroph. Later. Scler. Frontotemporal Degener. 16, 1\u20137 (2015).","journal-title":"Amyotroph. Later. Scler. Frontotemporal Degener."},{"issue":"5","key":"42075_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"M Charlson","year":"1987","unstructured":"Charlson, M., Pompei, P., Ales, K. & MacKenzie, C. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chronic Dis. 40(5), 373\u2013383 (1987).","journal-title":"J. Chronic Dis."},{"issue":"2","key":"42075_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"M Miller","year":"2005","unstructured":"Miller, M. et al. Standardisation of spirometry. Eur. Respir. J. 26(2), 319\u2013338 (2005).","journal-title":"Eur. Respir. J."},{"issue":"2","key":"42075_CR16","first-page":"127","volume":"62","author":"A Wever","year":"1981","unstructured":"Wever, A., Britton, M., Hughes, D., Van der Plas, K. & Wever-Hess, J. Clinical evaluation of five spirometers. Monaghan M403, Pneumoscreen, Spirotron, Vicatest and Vitalograph. Eur. J. Respir. Dis. 62(2), 127\u2013137 (1981).","journal-title":"Eur. J. Respir. Dis."},{"issue":"24","key":"42075_CR17","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1001\/jama.2019.7233","volume":"321","author":"S Bhatt","year":"2019","unstructured":"Bhatt, S. et al. Discriminative accuracy of FEV1:FVC thresholds for COPD-related hospitalization and mortality. JAMA 321(24), 2438\u20132447 (2019).","journal-title":"JAMA"},{"issue":"20","key":"42075_CR18","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1212\/WNL.0b013e3181c1df1e","volume":"73","author":"A Chi\u00f2","year":"2009","unstructured":"Chi\u00f2, A. et al. Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology 73(20), 1681\u20131685 (2009).","journal-title":"Neurology"},{"issue":"1","key":"42075_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neurol.2015.11.002","volume":"172","author":"P Couratier","year":"2016","unstructured":"Couratier, P. et al. Epidemiology of amyotrophic lateral sclerosis: A review of literature. Revue neurologique 172(1), 37\u201345 (2016).","journal-title":"Revue neurologique"},{"issue":"6","key":"42075_CR20","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/jnnp-2018-319611","volume":"90","author":"C Moglia","year":"2019","unstructured":"Moglia, C. et al. Early weight loss in amyotrophic lateral sclerosis: Outcome relevance and clinical correlates in a population-based cohort. J. Neurol. Neurosurg. Psychiatry 90(6), 666\u2013673 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"42075_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12883-018-1219-9","volume":"18","author":"C Yu","year":"2018","unstructured":"Yu, C. et al. The clinical assessment of amyotrophic lateral sclerosis patients\u2019 prognosis by ZNF512B gene, neck flexor muscle power score and body mass index (BMI). BMC Neurol. 18(1), 211 (2018).","journal-title":"BMC Neurol."},{"key":"42075_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jns.2014.02.035","volume":"340","author":"S Ngo","year":"2014","unstructured":"Ngo, S., Steyn, F. & McCombe, P. Body mass index and dietary intervention: Implications for prognosis of amyotrophic lateral sclerosis. J. Neurol. Sci. 340, 5\u201312 (2014).","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"42075_CR23","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.3390\/jcm10081623","volume":"10","author":"M Requardt","year":"2021","unstructured":"Requardt, M., G\u00f6rlich, D., Grehl, T. & Boentert, M. Clinical determinants of disease progression in amyotrophic lateral sclerosis-A retrospective cohort study. J. Clin. Med. 10(8), 1623 (2021).","journal-title":"J. Clin. Med."},{"key":"42075_CR24","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1164\/rccm.202005-1990OC","volume":"203","author":"P Burney","year":"2020","unstructured":"Burney, P. et al. Prevalence and population attributable risk for chronic airflow obstruction in a large multinational study. Am. J. Respir. Crit. Care Med. 203, 1353\u20131365 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"42075_CR25","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","volume":"80","author":"M Wyss","year":"2000","unstructured":"Wyss, M. & Kaddurah-Daouk, R. Creatine and creatinine metabolism. Physiol. Rev. 80(3), 1107\u20131213 (2000).","journal-title":"Physiol. Rev."},{"issue":"2","key":"42075_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/clinchem\/32.2.371","volume":"32","author":"R Swaminathan","year":"1986","unstructured":"Swaminathan, R., Ho, C., Chu, L. & Donnan, S. Relation between plasma creatinine and body size. Clin. Chem. 32(2), 371\u2013373 (1986).","journal-title":"Clin. Chem."},{"issue":"6","key":"42075_CR27","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/jnnp.2010.236752","volume":"82","author":"N Sutedja","year":"2011","unstructured":"Sutedja, N. et al. Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 82(6), 638\u2013642 (2011).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"13","key":"42075_CR28","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","volume":"70","author":"L Dupuis","year":"2008","unstructured":"Dupuis, L. et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 70(13), 1004\u20131009 (2008).","journal-title":"Neurology"},{"issue":"4","key":"42075_CR29","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S2213-2600(15)00050-8","volume":"3","author":"D Korevaar","year":"2015","unstructured":"Korevaar, D. et al. Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: A systematic review and meta-analysis. Lancet Respir. Med. 3(4), 290\u2013300 (2015).","journal-title":"Lancet Respir. Med."},{"issue":"9","key":"42075_CR30","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1164\/rccm.201701-0193OC","volume":"195","author":"N Roche","year":"2017","unstructured":"Roche, N. et al. Blood eosinophils and response to maintenance chronic obstructive pulmonary disease treatment data from the FLAME trial. Am. J. Respir. Crit. Care Med. 195(9), 1189\u20131197 (2017).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"42075_CR31","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/j.jaci.2018.09.038","volume":"143","author":"A Wang","year":"2019","unstructured":"Wang, A., Datta, S., Weiss, S. & Tantisira, K. Remission of persistent childhood asthma: Early predictors of adult outcomes. J. Allergy Clin. Immunol. 143(5), 1752-1759.e1756 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"42075_CR32","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S2213-2600(16)00100-4","volume":"4","author":"H Watz","year":"2016","unstructured":"Watz, H. et al. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: A post-hoc analysis of the WISDOM trial. Lancet Respir. Med. 4(5), 390\u2013398 (2016).","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"42075_CR33","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.jaci.2015.08.024","volume":"137","author":"B Salter","year":"2016","unstructured":"Salter, B. et al. Expression of activation markers in circulating basophils and the relationship to allergen-induced bronchoconstriction in subjects with mild allergic asthma. J. Allergy Clin. Immunol. 137(3), 936-938.e937 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"42075_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jaci.2021.02.045","volume":"148","author":"W Stevens","year":"2021","unstructured":"Stevens, W. et al. Studies of the role of basophils in aspirin-exacerbated respiratory disease pathogenesis. J. Allergy Clin. Immunol. 148(2), 439-449.e435 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"42075_CR35","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3233\/JAD-2012-111592","volume":"30","author":"K Lunnon","year":"2012","unstructured":"Lunnon, K. et al. Mitochondrial dysfunction and immune activation are detectable in early Alzheimer\u2019s disease blood. J. Alzheimer\u2019s Dis. JAD 30(3), 685\u2013710 (2012).","journal-title":"J. Alzheimer's Dis. JAD"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42075-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42075-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42075-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T13:21:22Z","timestamp":1700400082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42075-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["42075"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-42075-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"assertion":[{"value":"27 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15695"}}